This case preserves mouse CDRs while humanizing framework regions to retain DNAM-1 binding and reduce immunogenicity.
Dual toxic-protein cassettes simplify donor cloning and selection, enabling modified cell lines in less than 10 days.
A modular CAR combines CLD18A2 recognition with CD3ζ and co-stimulatory signaling to target tumors and limit off-target toxicity.
Asparagine-supplemented glutamine-free CHO media limits ammonia and supports protein titer.
This case uses defined peptide epitopes to improve tumor recognition while seeking fewer side effects than broad cancer treatments.